Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lindsley

Showing results (261-270 of 570) with videos related to

Pageof 57
Sort By:
ACS Chemical Neuroscience|February 24, 2017
Disease-Modifying Effects of M<sub>1</sub> Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse ModelEvan P Lebois, Jason P Schroeder, Thomas J Esparza, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2017
Synthesis and evaluation of 4,6-disubstituted pyrimidines as CNS penetrant pan-muscarinic antagonists with a novel chemotypeAaron M Bender, Rebecca L Weiner, Vincent B Luscombe, et al.
ACS Medicinal Chemistry Letters|July 14, 2026
Optimization of Pyrazole-Based Activators of Kv3.1Paul K Spearing, Vaishali Satpute Janke, Ian M Romaine, et al.
Biological Psychiatry|April 21, 2019
M<sub>1</sub> Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJames Maksymetz, Max E Joffe, Sean P Moran, et al.
Neuropharmacology|March 10, 2015
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonistHanna Iderberg, Natallia Maslava, Analisa D Thompson, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2020
Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitorsDarren W Engers, Sean R Bollinger, Andrew S Felts, et al.
Chemmedchem|September 12, 2014
Discovery of a highly selective PLD2 inhibitor (ML395): a new probe with improved physiochemical properties and broad-spectrum antiviral activity against influenza strainsMatthew C O'Reilly, Thomas H Oguin, Sarah A Scott, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2014
Discovery and SAR of muscarinic receptor subtype 1 (M1) allosteric activators from a molecular libraries high throughput screen. Part 1: 2,5-dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones as positive allosteric modulatorsChangho Han, Arindam Chatterjee, Meredith J Noetzel, et al.
ACS Omega|August 29, 2019
Evaluation of Synthetic Cytochrome P<sub>450</sub>-Mimetic Metalloporphyrins To Facilitate "Biomimetic" Biotransformation of a Series of mGlu<sub>5</sub> Allosteric LigandsChristopher C Presley, Charles K Perry, Elizabeth S Childress, et al.
Frontiers in Neuroscience|July 19, 2021
Partial mGlu<sub>5</sub> Negative Allosteric Modulator M-5MPEP Demonstrates Antidepressant-Like Effects on Sleep Without Affecting Cognition or Quantitative EEGKimberly M Holter, Alex D Lekander, Christina M LaValley, et al.
Pageof 57

Showing results (261-270 of 570) with videos related to

Sort By:
Pageof 57
ACS Chemical Neuroscience|February 24, 2017
Disease-Modifying Effects of M<sub>1</sub> Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse ModelEvan P Lebois, Jason P Schroeder, Thomas J Esparza, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2017
Synthesis and evaluation of 4,6-disubstituted pyrimidines as CNS penetrant pan-muscarinic antagonists with a novel chemotypeAaron M Bender, Rebecca L Weiner, Vincent B Luscombe, et al.
ACS Medicinal Chemistry Letters|July 14, 2026
Optimization of Pyrazole-Based Activators of Kv3.1Paul K Spearing, Vaishali Satpute Janke, Ian M Romaine, et al.
Biological Psychiatry|April 21, 2019
M<sub>1</sub> Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJames Maksymetz, Max E Joffe, Sean P Moran, et al.
Neuropharmacology|March 10, 2015
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonistHanna Iderberg, Natallia Maslava, Analisa D Thompson, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2020
Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitorsDarren W Engers, Sean R Bollinger, Andrew S Felts, et al.
Chemmedchem|September 12, 2014
Discovery of a highly selective PLD2 inhibitor (ML395): a new probe with improved physiochemical properties and broad-spectrum antiviral activity against influenza strainsMatthew C O'Reilly, Thomas H Oguin, Sarah A Scott, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2014
Discovery and SAR of muscarinic receptor subtype 1 (M1) allosteric activators from a molecular libraries high throughput screen. Part 1: 2,5-dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones as positive allosteric modulatorsChangho Han, Arindam Chatterjee, Meredith J Noetzel, et al.
ACS Omega|August 29, 2019
Evaluation of Synthetic Cytochrome P<sub>450</sub>-Mimetic Metalloporphyrins To Facilitate "Biomimetic" Biotransformation of a Series of mGlu<sub>5</sub> Allosteric LigandsChristopher C Presley, Charles K Perry, Elizabeth S Childress, et al.
Frontiers in Neuroscience|July 19, 2021
Partial mGlu<sub>5</sub> Negative Allosteric Modulator M-5MPEP Demonstrates Antidepressant-Like Effects on Sleep Without Affecting Cognition or Quantitative EEGKimberly M Holter, Alex D Lekander, Christina M LaValley, et al.
Pageof 57